Adolescent THC and Kynurenic Acid: What a Rat Intervention Adds to a Correlation
A rat experiment linked prior adolescent THC exposure with elevated prefrontal kynurenic acid and later memory deficits, then tested an intervention affecting that pathway. The intervention strengthens a mechanistic hypothesis without establishing a treatment for humans.
Exposure, chemistry, and behavior
Beggiato and colleagues administered ascending THC doses to male Wistar rats during adolescence. In adulthood, they assessed spontaneous alternation in a Y-maze and extracellular prefrontal kynurenic acid and glutamate using microdialysis.
Microdialysis samples a local extracellular environment. These measurements are not whole-blood drug levels, a clinical brain scan, or a direct measure of every synapse.
A selective biochemical result
Previously exposed rats had higher basal kynurenic acid and poorer short-term-memory performance. Basal extracellular glutamate did not significantly change. A kynurenine challenge increased kynurenic acid in both exposed and control animals.
A brain-penetrant inhibitor of kynurenic-acid synthesis improved the cognitive outcome in the exposed animals. That finding goes beyond simply observing two altered measurements together, but it does not establish that this pathway is the sole cause of every THC-associated cognitive effect.
What remains unproven?
The study involved a particular adolescent dosing regimen, male rats, a local biochemical endpoint, and selected memory tasks. It did not establish efficacy, safety, dosing, or persistence of benefit in people.
The results should not be presented as a supplement recommendation or a way to clear an acutely impaired driver. They identify an experimental mechanism and candidate intervention for further research. Individual human symptoms still require assessment of exposure history, other illnesses, and alternative explanations.
The adolescent exposure occurred on postnatal days 35–45, with adult evaluation on day 75. The tested intervention was PF-04859989, an inhibitor of kynurenine aminotransferase II, the enzyme involved in kynurenic-acid synthesis. This sequence examines a later consequence of prior exposure; it does not describe the clearance of THC from a newly collected blood specimen.
Related reading: interpreting selective spatial-memory findings.
Primary research
Sarah Beggiato; Alessandro Ieraci; Mariachiara Zuccarini; Patrizia Di Iorio; Robert Schwarcz; Luca Ferraro. Alterations in rat prefrontal cortex kynurenic acid levels are involved in the enduring cognitive dysfunctions induced by tetrahydrocannabinol exposure during the adolescence. Frontiers in Psychiatry (2022). DOI: 10.3389/fpsyt.2022.996406.
